Preprint · CC-BY
via OpenAlex
Evaluation of a Synthetic Spermidine–Spermine Supplement with Arginine and BB12: Safety Outcomes and Beclin-1 Modulation in a Randomized Placebo-Controlled Pilot Trial in Older Adults
Robert Lustig, William John Watkins, Stefano Natella, Pedro Velasquez‐Mieyer, Lucy Jones
Research Square · 2026
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-9252335/v1
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Lustig, R., Watkins, W.J., Natella, S., Velasquez‐Mieyer, P., & Jones, L. (2026). Evaluation of a Synthetic Spermidine–Spermine Supplement with Arginine and BB12: Safety Outcomes and Beclin-1 Modulation in a Randomized Placebo-Controlled Pilot Trial in Older Adults. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-9252335/v1
Vancouver
Lustig R, Watkins WJ, Natella S, Velasquez‐Mieyer P, Jones L. Evaluation of a Synthetic Spermidine–Spermine Supplement with Arginine and BB12: Safety Outcomes and Beclin-1 Modulation in a Randomized Placebo-Controlled Pilot Trial in Older Adults. Research Square. 2026. doi:10.21203/rs.3.rs-9252335/v1.
BibTeX
@unpublished{robert2026Evalua,
title = {Evaluation of a Synthetic Spermidine–Spermine Supplement with Arginine and BB12: Safety Outcomes and Beclin-1 Modulation in a Randomized Placebo-Controlled Pilot Trial in Older Adults},
author = {Robert Lustig and William John Watkins and Stefano Natella and Pedro Velasquez‐Mieyer and Lucy Jones},
journal = {Research Square},
year = {2026},
doi = {10.21203/rs.3.rs-9252335/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
GeroScience 2023
Preprint · OA
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
Wake Forest University Health Sciences 2022
Open access · US-GOV
Health, Aging and Later-Life Outcomes Pilot Trial (HALLO-P): A 9-month Randomized Pilot Trial of 3 Nutritional Interventions in 120 Older Adults With an Indication for Weight Loss
Yikang Biotech (Suzhou) Co., Ltd. 2026
Open access · US-GOV
A Randomized, Blinded, Placebo-Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) in Adults Aged 18 Years and Older
University of South Florida 2011
Open access · US-GOV
Phase II Study of a Nutraceutical on the Cognitive Performance of Older Adults.
Indiana University 2010
Open access · US-GOV